Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
26 Prestige Biopharma IDC to Host First International Symposium on Emerging Biopharmaceutical Modalities
김** | 2024.11.15 | Votes 0 | Views 331
김** 2024.11.15 0 331
25 Prestige Biopharma IDC Opens New Innovative Discovery Center in Busan
김** | 2024.11.15 | Votes 0 | Views 497
김** 2024.11.15 0 497
24 Prestige Biopharma IDC CEO Sang-Seok Koh Receives Presidential Commendation
we******** | 2024.11.06 | Votes 0 | Views 348
we******** 2024.11.06 0 348
23 Prestige Biopharma IDC and Aptis Sign Collaboration for Next-Generation ADC Cancer Therapy Development
we******** | 2024.09.26 | Votes 0 | Views 360
we******** 2024.09.26 0 360
22 Prestige Biopharma Receives European Commission Approval for Herceptin Biosimilar Tuznue®
we******** | 2024.09.23 | Votes 0 | Views 637
we******** 2024.09.23 0 637
21 Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
김** | 2024.06.16 | Votes 0 | Views 752
김** 2024.06.16 0 752
20 Prestige Biopharma IDC Appoints Dr. Koh Sang-seok, Discoverer of PAUF Protein, as CEO
김** | 2024.03.05 | Votes 0 | Views 353
김** 2024.03.05 0 353
19 Prestige Biopharma Explores Global Expansion of PAUF-Based Pancreatic Cancer Diagnostic Kit at MEDICA 2023
we******** | 2023.11.16 | Votes 0 | Views 315
we******** 2023.11.16 0 315
18 Prestige Biopharma Secures Chinese Patent for PBP1510, a First-in-Class Anti-PAUF Antibody for Pancreatic Cancer
we******** | 2023.11.07 | Votes 0 | Views 459
we******** 2023.11.07 0 459
17 Prestige Biopharma Group Signs Strategic CDMO Partnership with Dr. Reddy’s Laboratories
김** | 2023.09.22 | Votes 0 | Views 536
김** 2023.09.22 0 536

Read Prestige news >>